ALK and lung carcinoma: Won et al. analyzed the EGFR and ALK status in 1,458 cases of lung cancer including NSCLC (n = 1,445) and small-cell carcinoma (n = 13) using direct sequencing and FISH, respectively, and the cohort enrolled in the study are from Seoul, Korea.